Title : Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.

Pub. Date : 2018 Jul

PMID : 29065744






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) is associated with worse survival after standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) chemoimmunotherapy compared to germinal center B-cell-like (GCB) subtype. Vincristine ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens
2 Activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) is associated with worse survival after standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) chemoimmunotherapy compared to germinal center B-cell-like (GCB) subtype. Vincristine ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens